obudanersen

Drug identity checked against registry records

Also recorded as ION582

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
REVEAL: A Phase 3 Study of Obudanersen (ION582) in Angelman SyndromeNCT06914609IONSPhase 3Active not recruiting2027-08Estimated
CHAMPION: A Study to Evaluate the Efficacy and Safety of Obudanersen (ION582) in Children and Adults With Angelman Syndrome (AS)NCT07782827IONSPhase 3Recruiting2028-05Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.